- Report
- May 2024
- 136 Pages
Global
From €5764EUR$6,499USD£5,000GBP
- Report
- May 2024
- 137 Pages
Global
From €5764EUR$6,499USD£5,000GBP
- Report
- May 2024
- 140 Pages
Global
From €5764EUR$6,499USD£5,000GBP
- Report
- May 2024
- 136 Pages
Global
From €5764EUR$6,499USD£5,000GBP
- Report
- May 2024
- 128 Pages
Global
From €5764EUR$6,499USD£5,000GBP
- Report
- May 2024
- 140 Pages
Global
From €5764EUR$6,499USD£5,000GBP
- Report
- May 2021
- 50 Pages
China
From €2306EUR$2,600USD£2,000GBP
- Drug Pipelines
- February 2022
- 74 Pages
Global
From €3503EUR$3,950USD£3,039GBP
- Report
- January 2022
- 200 Pages
Global
From €6652EUR$7,500USD£5,770GBP
- Report
- January 2024
- 200 Pages
Global
From €3681EUR$4,150USD£3,193GBP
- Report
- June 2024
- 200 Pages
Global
From €7051EUR$7,950USD£6,116GBP
- Report
- January 2022
- 60 Pages
Global
From €3503EUR$3,950USD£3,039GBP
- Report
- July 2024
- 180 Pages
Global
From €3991EUR$4,500USD£3,462GBP
- Report
- April 2024
- 183 Pages
Global
From €3991EUR$4,500USD£3,462GBP
- Report
- February 2024
- 179 Pages
Global
From €3991EUR$4,500USD£3,462GBP
- Report
- February 2024
- 184 Pages
Global
From €3991EUR$4,500USD£3,462GBP
- Report
- November 2023
- 189 Pages
Global
From €3991EUR$4,500USD£3,462GBP
- Report
- October 2023
- 172 Pages
Global
From €3991EUR$4,500USD£3,462GBP
- Report
- December 2024
- 82 Pages
Vietnam
From €3104EUR$3,500USD£2,693GBP
- Report
- May 2024
- 187 Pages
Global
From €3991EUR$4,500USD£3,462GBP

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs.
Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more